# Ultragenyx Pharmaceutical Inc. (RARE) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$575M |
| 2024 | -$569M |
| 2023 | -$607M |
| 2022 | -$707M |
| 2021 | -$454M |
| 2020 | -$187M |
| 2019 | -$403M |
| 2018 | -$198M |
| 2017 | -$302M |
| 2016 | -$246M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2026-03-31 | -$185M |
| 2025-09-30 | -$180M |
| 2025-06-30 | -$115M |
| 2025-03-31 | -$151M |
| 2024-09-30 | -$134M |
| 2024-06-30 | -$132M |
| 2024-03-31 | -$171M |
| 2023-09-30 | -$160M |
| 2023-06-30 | -$160M |
| 2023-03-31 | -$164M |
| 2022-09-30 | -$245M |
| 2022-06-30 | -$158M |
| 2022-03-31 | -$152M |
| 2021-09-30 | -$73M |
| 2021-06-30 | -$122M |
| 2021-03-31 | -$136M |
| 2020-09-30 | -$69M |
| 2020-06-30 | $25M |
| 2020-03-31 | -$119M |
| 2019-09-30 | -$113M |
| 2019-06-30 | -$99M |
| 2019-03-31 | -$97M |
| 2018-09-30 | -$87M |
| 2018-06-30 | -$53M |

Source: [CompaniesByCap](https://companiesbycap.com/company/RARE/net-income)